MedTrace Logo

Modafinil for the Treatment of Cocaine Dependence - 1

NCT00100100 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Modafinil

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Domenic Ciraulo, M.D. · Boston University

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00100100 on ClinicalTrials.gov